0.9615
price down icon1.82%   -0.0178
after-market After Hours: 1.00 0.0385 +4.00%
loading
Immunic Inc stock is traded at $0.9615, with a volume of 644.38K. It is down -1.82% in the last 24 hours and up +37.85% over the past month. Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
See More
Previous Close:
$0.9793
Open:
$0.9981
24h Volume:
644.38K
Relative Volume:
0.37
Market Cap:
$92.13M
Revenue:
-
Net Income/Loss:
$-93.61M
P/E Ratio:
-0.4557
EPS:
-2.11
Net Cash Flow:
$-71.16M
1W Performance:
-3.56%
1M Performance:
+37.85%
6M Performance:
-5.74%
1Y Performance:
-31.32%
1-Day Range:
Value
$0.95
$1.00
1-Week Range:
Value
$0.9426
$1.18
52-Week Range:
Value
$0.561
$2.11

Immunic Inc Stock (IMUX) Company Profile

Name
Name
Immunic Inc
Name
Phone
(332) 255-9818
Name
Address
1200 AVENUE OF THE AMERICAS, NEW YORK
Name
Employee
90
Name
Twitter
@ImmunicInc
Name
Next Earnings Date
2025-03-17
Name
Latest SEC Filings
Name
IMUX's Discussions on Twitter

Compare IMUX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
IMUX
Immunic Inc
0.9615 103.48M 0 -93.61M -71.16M -2.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.16 118.34B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
554.58 60.31B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
339.80 42.35B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
598.89 36.43B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.94 31.87B 3.81B -644.79M -669.77M -6.24

Immunic Inc Stock (IMUX) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-25-25 Initiated William Blair Outperform
Nov-25-24 Initiated H.C. Wainwright Buy
Sep-09-24 Resumed Leerink Partners Outperform
Aug-27-24 Initiated B. Riley Securities Buy
Oct-21-22 Downgrade SVB Leerink Outperform → Mkt Perform
Sep-19-22 Resumed H.C. Wainwright Buy
Apr-15-21 Initiated Aegis Capital Buy
Mar-24-21 Initiated JMP Securities Mkt Outperform
Oct-02-20 Initiated SVB Leerink Outperform
Aug-26-20 Initiated Piper Sandler Overweight
Aug-07-20 Resumed ROTH Capital Buy
Jul-20-20 Initiated BMO Capital Markets Outperform
Jun-05-20 Initiated Wedbush Outperform
May-11-20 Initiated H.C. Wainwright Buy
Mar-25-20 Initiated ROTH Capital Buy
Jul-11-19 Initiated Chardan Capital Markets Buy
View All

Immunic Inc Stock (IMUX) Latest News

pulisher
Jul 28, 2025

How Immunic Inc. stock performs during market volatilityShort Term Trading Opportunity Watch Sees Shift - beatles.ru

Jul 28, 2025
pulisher
Jul 28, 2025

What is the dividend policy of Immunic Inc. stockBuild wealth with long-term growth strategies - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are analysts’ price targets for Immunic Inc. in the next 12 monthsCapitalize on emerging market trends - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Should I hold or sell Immunic Inc. stock in 2025Triple-digit profit margins - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is it the right time to buy Immunic Inc. stockFree Predictions - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What is Immunic Inc. company’s growth strategyBreakthrough profit margins - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

When is Immunic Inc. stock expected to show significant growthIdentify safe investments with exceptional yields - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What is the risk reward ratio of investing in Immunic Inc. stockGame-changing returns - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Immunic Inc. a growth stock or a value stockAchieve rapid portfolio growth with smart picks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the technical indicators suggesting about Immunic Inc.Free Consultation - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 26, 2025

Immunic, Inc.'s (NASDAQ:IMUX) market cap touched US$103m last week, benefiting both individual investors who own 55% as well as institutions - simplywall.st

Jul 26, 2025
pulisher
Jul 25, 2025

Immunic Reports Positive Long-Term Safety, Tolerability Data for Vidofludimus Calcium in MS Trial - Insider Monkey

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Immunic Inc. stock priceRapid return acceleration - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Immunic Inc. stockRecord-breaking gains - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

How Immunic Inc. stock reacts to Fed policy changesPowerful profit generation - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Immunic Inc. Stock Analysis and ForecastRapid growth opportunities - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

How high can Immunic Inc. stock price go in 2025Accelerated earnings growth - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Is Immunic Inc. a good long term investmentBreakthrough profits - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Immunic, Inc. shares fall 2.01% premarket after AstraZeneca's immune disorder drug succeeds in late-stage trial. - AInvest

Jul 24, 2025
pulisher
Jul 23, 2025

12 Best Penny Stocks Under $1 to Buy Now - Insider Monkey

Jul 23, 2025
pulisher
Jul 22, 2025

World Brain Day: Immunic targets MS with new therapy - Proactive financial news

Jul 22, 2025
pulisher
Jul 17, 2025

IMUX’s Stock Market Puzzle: Piecing Together 2025’s Performance - investchronicle.com

Jul 17, 2025
pulisher
Jul 15, 2025

What makes Immunic Inc. stock price move sharplyValue Pick Scanner - Newser

Jul 15, 2025

Immunic Inc Stock (IMUX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Immunic Inc Stock (IMUX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Tardio Jason
President and COO
Jun 05 '25
Buy
0.79
12,512
9,884
12,512
Vitt Daniel
CEO and Director
Jun 04 '25
Buy
0.77
15,000
11,550
29,000
Neermann Joerg
Director
Jun 04 '25
Buy
0.77
70,000
53,900
170,000
Neermann Joerg
Director
Jun 05 '25
Buy
0.76
30,000
22,800
200,000
Whaley Glenn
Chief Financial Officer
Jun 03 '25
Buy
0.71
45,000
32,076
95,510
Rudick Richard Alan
Director
Jun 03 '25
Buy
0.70
143,075
100,024
230,375
Rudick Richard Alan
Director
Nov 12 '24
Buy
1.15
87,300
100,369
87,300
$77.55
price up icon 0.23%
$37.12
price down icon 0.40%
$105.18
price up icon 0.17%
$26.66
price down icon 0.30%
$110.05
price down icon 1.28%
biotechnology ONC
$299.94
price down icon 1.90%
Cap:     |  Volume (24h):